BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24486109)

  • 1. Molecular docking study, synthesis and biological evaluation of Schiff bases as Hsp90 inhibitors.
    Dutta Gupta S; Snigdha D; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
    Biomed Pharmacother; 2014 Apr; 68(3):369-76. PubMed ID: 24486109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach.
    Gupta SD; Swapanthi PS; Bhagya D; Federicci F; Mazaira GI; Galigniana MD; Subrahmanyam CVS; Gowrishankar NL; Raghavendra NM
    Anticancer Agents Med Chem; 2020; 20(3):369-385. PubMed ID: 31713499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,4-dihydroxy benzaldehyde derived Schiff bases as small molecule Hsp90 inhibitors: rational identification of a new anticancer lead.
    Dutta Gupta S; Revathi B; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
    Bioorg Chem; 2015 Apr; 59():97-105. PubMed ID: 25727264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking study, synthesis and biological evaluation of Mannich bases as Hsp90 inhibitors.
    Dutta Gupta S; Bommaka MK; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
    Int J Biol Macromol; 2015 Sep; 80():253-9. PubMed ID: 26116388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Design, Synthesis and In Vitro Evaluation of Substituted Benzofurans as Hsp90 Inhibitors.
    Kadasi S; Costa TEMM; Arukala N; Toshakani M; Duggineti C; Thota S; Dutta Gupta S; Raj S; Penido C; Henriques MG; Raghavendra NM
    Med Chem; 2018; 14(1):44-52. PubMed ID: 28641528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.
    Casale E; Amboldi N; Brasca MG; Caronni D; Colombo N; Dalvit C; Felder ER; Fogliatto G; Galvani A; Isacchi A; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Casuscelli F
    Bioorg Med Chem; 2014 Aug; 22(15):4135-50. PubMed ID: 24980703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents.
    Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS
    Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity.
    Ameri A; Khodarahmi G; Hassanzadeh F; Forootanfar H; Hakimelahi GH
    Arch Pharm (Weinheim); 2016 Aug; 349(8):662-81. PubMed ID: 27320785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold.
    Jia JM; Liu F; Xu XL; Guo XK; Jiang F; Cherfaoui B; Sun HP; You QD
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1557-61. PubMed ID: 24582477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents.
    Kavalapure RS; Alegaon SG; Venkatasubramanian U; Priya AS; Ranade SD; Khanal P; Mishra S; Patil D; Salve PS; Jalalpure SS
    Bioorg Chem; 2021 Nov; 116():105381. PubMed ID: 34601297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure based design of heat shock protein 90 inhibitors acting as anticancer agents.
    Doddareddy MR; Thorat DA; Seo SH; Hong TJ; Cho YS; Hahn JS; Pae AN
    Bioorg Med Chem; 2011 Mar; 19(5):1714-20. PubMed ID: 21306907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis.
    Koca İ; Özgür A; Er M; Gümüş M; Açikalin Coşkun K; Tutar Y
    Eur J Med Chem; 2016 Oct; 122():280-290. PubMed ID: 27376491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
    Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
    Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
    J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-I Knoevenagel's condensates and their Schiff's bases as anticancer agents: synthesis, pharmacological and simulation studies.
    Ali I; Haque A; Saleem K; Hsieh MF
    Bioorg Med Chem; 2013 Jul; 21(13):3808-20. PubMed ID: 23643901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, crystal structures, antiproliferative activities and reverse docking studies of eight novel Schiff bases derived from benzil.
    Tan XJ; Wang D; Hei XM; Yang FC; Zhu YL; Xing DX; Ma JP
    Acta Crystallogr C Struct Chem; 2020 Jan; 76(Pt 1):44-63. PubMed ID: 31919307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and antitumor activity of anthracene-9-carbaldehyde amino-s-triazole Schiff-bases with side-chain of S-acetic acid].
    Hu GQ; Dong XL; Xie SQ; Huang WL
    Yao Xue Xue Bao; 2008 Jan; 43(1):50-3. PubMed ID: 18357731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors.
    Dal Piaz F; Vassallo A; Temraz A; Cotugno R; Belisario MA; Bifulco G; Chini MG; Pisano C; De Tommasi N; Braca A
    J Med Chem; 2013 Feb; 56(4):1583-95. PubMed ID: 23362862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
    Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined pharmacophore and structure-guided studies to identify diverse HSP90 inhibitors.
    Sanam R; Tajne S; Gundla R; Vadivelan S; Machiraju PK; Dayam R; Narasu L; Jagarlapudi S; Neamati N
    J Mol Graph Model; 2010 Feb; 28(6):472-7. PubMed ID: 20005756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.